Evidence map›Paper›PMID 36298768›Full record

ReviewViruses2022

The Japanese Encephalitis Antigenic Complex Viruses: From Structure to Immunity.

Baldeep Khare, Richard J Kuhn

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Baldeep KhareDepartment of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA.
Richard J KuhnDepartment of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA.
Purdue University West Lafayette · US

Funding

Antibody-based Protection against FlavivirsesR01AI073755 · NIAID · WASHINGTON UNIVERSITY · PI DIAMOND, MICHAEL S, FREMONT, DAVED H. · 2007 to 2022
$11.4M
Structural Studies of TogavirusesR01AI095366 · NIAID · PURDUE UNIVERSITY · PI KUHN, RICHARD J. · 2012 to 2023
$6.8M
ANTIBODY-BASED PROTECTION AGAINST FLAVIVIRUSESU01AI073755 · NIAID · WASHINGTON UNIVERSITY · PI James E Crowe, Michael S Diamond · 2024 to 2026
$3.3M
NIAID NIH HHS R01 AI073755NIAID NIH HHS R01 AI095366NIAID NIH HHS U01 AI073755NIH HHS AI073755 and AI095366 to R.J.K
6 · The paper itself

Abstract

In the last three decades, several flaviviruses of concern that belong to different antigenic groups have expanded geographically. This has resulted in the presence of often more than one virus from a single antigenic group in some areas, while in Europe, Africa and Australia, additionally, multiple viruses belonging to the Japanese encephalitis (JE) serogroup co-circulate. Morphological heterogeneity of flaviviruses dictates antibody recognition and affects virus neutralization, which influences infection control. The latter is further impacted by sequential infections involving diverse flaviviruses co-circulating within a region and their cross-reactivity. The ensuing complex molecular virus-host interplay leads to either cross-protection or disease enhancement; however, the molecular determinants and mechanisms driving these outcomes are unclear. In this review, we provide an overview of the epidemiology of four JE serocomplex viruses, parameters affecting flaviviral heterogeneity and antibody recognition, host immune responses and the current knowledge of the cross-reactivity involving JE serocomplex flaviviruses that leads to differential clinical outcomes, which may inform future preventative and therapeutic interventions.

Indexed as

Encephalitis, JapaneseEncephalitis Viruses, JapaneseEncephalitis Virus, JapaneseFlavivirusWest Nile virusAntibodies, ViralCross ReactionsEuropeHumansAntibodies, Viralcross-reactivityenvelope proteinJapanese encephalitis serogroupJapanese encephalitis virusMurray valley encephalitis virusUsutu virusWest Nile virus

Identifiers

PMID36298768
PMCPMC9607441
OpenAlexW4304789035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.